¼¼°èÀÇ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀå
West Nile Virus
»óǰÄÚµå : 1551644
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2024³â 09¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 169 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,233,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,701,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀåÀº 2030³â±îÁö 9¾ï 2,910¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»ó

2023³â¿¡ 6¾ï 1,590¸¸ ´Þ·¯·Î Æò°¡µÈ ¼¼°èÀÇ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀåÀº 2030³â¿¡´Â 9¾ï 2,910¸¸ ´Þ·¯¿¡ À̸¦ Àü¸ÁÀ̸ç, ºÐ¼® ±â°£ 2023³âºÎÅÍ 2030³â±îÁö CAGRÀº 6.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Ç×¹ÙÀÌ·¯½ºÁ¦´Â CAGR 7.2%·Î ¼ºÀåÀ» Áö¼ÓÇϰí, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 3¾ï 8,480¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Ç×»ýÁ¦ ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 5.8%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 1¾ï 6,780¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 9.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹Ãø

¹Ì±¹ÀÇ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀåÀº 2023³â 1¾ï 6,780¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2023³âºÎÅÍ 2030³â±îÁö ºÐ¼® ±â°£¿¡ CAGR 9.9%·Î ÃßÀÌÇÒ Àü¸ÁÀ̸ç, 2030³â¿¡´Â ¿¹Ãø½ÃÀå ±Ô¸ð 2¾ï 70¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 2.4%¿Í 6.1%·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀå-ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à

¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º¶õ ¹«¾ùÀΰ¡, °øÁß º¸°Ç¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡´Â°¡?

¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º(WNV)´Â ¸ð±â¸¦ ÁßÀçÇÏ´Â ¹ÙÀÌ·¯½º·Î ¼¼°è °øÁß º¸°Ç¿¡ Áß¿äÇÑ ¹®Á¦·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. 1937³â ¿ì°£´Ù¿¡¼­ óÀ½ È®ÀÎµÈ ÀÌ·¡ ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÀÇ ÀϺθ¦ Æ÷ÇÔÇÑ ¼¼°è °¢Áö¿¡ ÆÛÁ® ÀÖ½À´Ï´Ù. WNV´Â ÁÖ·Î °¨¿°µÈ ¸ð±â, ƯÈ÷ ¸¹Àº Áö¿ª¿¡ ¼­½ÄÇÏ´Â Culex ¼Ó ¸ð±â¿¡ Âñ·Á¼­ Àΰ£À» °¨¿°½Ãŵ´Ï´Ù. WNV °¨¿°ÀÇ ´ëºÎºÐÀº ¹«Áõ»óÀ̰ųª °¡º­¿î ÀÎÇ÷翣ÀÚ¿Í °°Àº Áõ»óÀÌÁö¸¸, ÀÌ ¹ÙÀÌ·¯½º´Â ƯÈ÷ ³ëÀΰú ¸é¿ª·ÂÀÌ ÀúÇÏµÈ »ç¶÷¿¡°Ô ³ú¿°°ú ¼ö¸·¿°°ú °°Àº ½ÉÇÑ ½Å°æ ÁúȯÀ» ÀÏÀ¸Å³ ¼ö ÀÖ½À´Ï´Ù. Àå±â°£ÀÇ ½Å°æÀå¾Ö³ª »ç¸Á µî ½É°¢ÇÑ °á°ú¸¦ ÃÊ·¡ÇÒ ¼ö Àֱ⠶§¹®¿¡ WNV´Â °øÁߺ¸°Ç¿¡ Áß¿äÇÑ ¹®Á¦°¡ µÇ°í ÀÖ½À´Ï´Ù. ¼¼°è ¿©Çà°ú ±âÈÄ º¯È­·Î ÀÎÇØ ¸ð±â ¼­½ÄÁö°¡ È®»êµÊ¿¡ µû¶ó WNV ¹ß»ý À§ÇèÀÌ °è¼Ó Áõ°¡Çϰí ÀÖÀ¸¸ç, °¨½Ã, ¿¹¹æ ¹× Ä¡·á °­È­°¡ ÇÊ¿äÇÕ´Ï´Ù.

¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½ºÀÇ °¨¿° À§ÇèÀÌ °¡Àå ³ôÀº »ç¶÷Àº ´©±¸ÀԴϱî? ¿Ö ±×·¸°Ô À§ÇèÇѰ¡?

¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º´Â ³ëÀÎ, ¸é¿ª °áÇÌÁõ, ´ç´¢º´ ¹× °íÇ÷¾Ð°ú °°Àº Áöº´À» °¡Áø »ç¶÷°ú °°Àº ƯÁ¤ °íÀ§Çè Áý´Ü¿¡ Ưº°ÇÑ À§ÇùÀ» ÁÝ´Ï´Ù. ÀÌ »ç¶÷µéÀº °¨¿°µÇ¸é ȸº¹ ±â°£ÀÌ ±æ¾îÁö°Å³ª ÈÄÀ¯ÁõÀÌ ³²À» ¼ö ÀÖ´Â ½Å°æ ÇÕº´Áõ°ú °°Àº ½É°¢ÇÑ Áõ»óÀ» ÀÏÀ¸Å³ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ¶ÇÇÑ WNV°¡ À¯ÇàÇÏ´Â Áö¿ª ÁֹεéÀº ƯÈ÷ ¸ð±â°¡ ´ë·®À¸·Î ¹ß»ýÇÏ´Â °èÀý¿¡ °¨¿°µÉ À§ÇèÀÌ ³ô¾ÆÁý´Ï´Ù. WNVÀÇ À§ÇèÀº ½É°¢ÇÑ Áúº´À» À¯¹ßÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó ¸¹Àº °æ¿ì°¡ ¹«Áõ»ó ¶Ç´Â ºñƯÀÌÀû Áõ»óÀ» ³ªÅ¸³»¹Ç·Î Á¶±â ¹ß°ßÀ» ÇÇÇÒ ¼ö ÀÖ´Â ´É·Â¿¡µµ ÀÖ½À´Ï´Ù. µû¶ó¼­ Áø´ÜÀ̳ª Ä¡·á°¡ Áö¿¬µÇ°í ÁßÁõÈ­µÉ °¡´É¼ºÀÌ ³ô¾ÆÁý´Ï´Ù. °øÁß º¸°Ç ´ç±¹Àº WNVÀÇ ¿µÇâÀ» ÁÙÀ̱â À§ÇØ ¸ð±â Á¦°Å ÇÁ·Î±×·¥, ³ëÃâÀ» ÁÙÀ̱â À§ÇÑ ÀÏ¹Ý ½Ã¹Î ±³À°, ¹é½Å ¹× Ç×¹ÙÀÌ·¯½º Ä¡·áÁ¦ °³¹ß µî ¿¹¹æ Á¶Ä¡ÀÇ Á߿伺À» °­Á¶ÇÕ´Ï´Ù.

¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ´ëÃ¥ÀÇ Ãֽе¿Çâ ¹× Çõ½ÅÀ̶õ?

¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º¿ÍÀÇ ½Î¿òÀº ŽÁö, ¿¹¹æ, Ä¡·á Àü·«ÀÇ °³¼±¿¡ ÁßÁ¡À» µÎ°í ÃÖ±Ù ¼ö¸¹Àº Áøº¸¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. °¡Àå Áß¿äÇÑ µ¿Çâ Áß Çϳª´Â WNV °¨¿°À» ½Å¼ÓÇÏ°Ô È®ÀÎÇÒ ¼ö ÀÖ´Â ½Å¼Ó Áø´Ü °Ë»çÀÇ °³¹ß·Î, Àû½Ã °³ÀÔÀÌ °¡´ÉÇØ ¹ÙÀÌ·¯½ºÀÇ È®»êÀ» ¾ïÁ¦ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, WNV¿¡ ´ëÇÑ Àå±âÀûÀÎ ¹æ¾î¸¦ °¡´ÉÇÏ°Ô ÇÏ´Â ¹é½ÅÀÇ ¿¬±¸µµ ÁøÇà ÁßÀ̸ç, À̴ ƯÈ÷ ¹ÙÀÌ·¯½º°¡ ÀÚÁÖ ¹ß»ýÇÏ´Â Áö¿ª¿¡¼­ ¹ÙÀÌ·¯½º¸¦ Á¦¾ÐÇϱâ À§ÇÑ Å« µ¹ÆÄ±¸°¡ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. À¯ÀüÀÚ º¯Çü ¸ð±â¿Í ȯ°æ ģȭÀûÀÎ »ìÃæÁ¦ »ç¿ë°ú °°Àº ¸ð±â Á¦°Å ±â¼úÀÇ ¹ßÀüÀº WNV º¸±ÕÀÚÀÇ ¼ö¸¦ ÁÙÀÌ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¶ÇÇÑ °øÁߺ¸°Ç Ä·ÆäÀο¡¼­´Â µðÁöÅÐ Ç÷§ÆûÀ» Ȱ¿ëÇÏ¿© WNV ¿¹¹æ¿¡ °üÇÑ Á¤º¸¸¦ ¹ß½ÅÇÒ ¼ö ÀÖ´Â ±âȸ°¡ ´Ã¾î³ª°í, °³ÀÎÀÇ ¹æÈ£ ´ëÃ¥À̳ª Áö¿ª ÀüüÀÇ ¸ð±â ±¸Á¦ ³ë·ÂÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Çõ½ÅÀº WNV¿¡ ´ëÇÑ º¸´Ù Á¾ÇÕÀûÀ̰í È¿°úÀûÀÎ ´ëÀÀ¿¡ ±â¿©Çϰí ÀÖÁö¸¸, ƯÈ÷ ÀÚ¿øÀÌ Á¦ÇÑµÈ È¯°æ¿¡¼­´Â ÀÌ·¯ÇÑ µµ±¸¿¡ ´ëÇÑ ¾×¼¼½º¸¦ ³Î¸® È®º¸ÇÏ´Â °ÍÀÌ °úÁ¦·Î ³²¾Æ ÀÖ½À´Ï´Ù.

¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀº?

¿þ½ºÆ® ³ªÀÏ ¹ÙÀÌ·¯½º ½ÃÀåÀÇ ¼ºÀåÀÇ ¿øµ¿·ÂÀºÀÌ ¹ÙÀÌ·¯½º°¡ ÃÊ·¡ÇÏ´Â À§Çù Áõ°¡¸¦ µÞ¹ÞħÇÏ´Â ¸î °¡Áö ¿äÀÎÀÔ´Ï´Ù. ÁÖ¿ä ¿äÀÎÀº WNV¸¦ ¸Å°³ÇÏ´Â ¸ð±â ¼­½ÄÁö¸¦ »õ·Î¿î Áö¿ªÀ¸·Î È®ÀåÇÏ´Â ¼¼°èÀÇ ±âÈÄ º¯È­¿¡ ÈûÀÔ¾î WNV ¹ß»ý Áõ°¡ÀÔ´Ï´Ù. ÀÌ Ãß¼¼´Â º¸´Ù È¿°úÀûÀÎ ¸ð´ÏÅ͸µ, Áø´Ü ¹× ¿¹¹æ Á¶Ä¡¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÕ´Ï´Ù. ƯÈ÷ Áø´Ü ¹× ¸ð±â Á¦°Å ºÐ¾ßÀÇ ±â¼ú Áøº¸´Â WNVÀÇ °ËÃâ°ú È®»êÀ» ¿ÏÈ­Çϱâ À§ÇÑ º¸´Ù È¿À²ÀûÀ̰í È®Àå °¡´ÉÇÑ ¼Ö·ç¼ÇÀ» Á¦°øÇÔÀ¸·Î½á ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. WNV°¡ ½É°¢ÇÑ ½Å°æÁúȯÀ» ÀÏÀ¸Å³ ¼ö ÀÖ´Ù´Â ÀÎ½Ä Áõ°¡´Â ¸ð±âÀÇ ±¸Á¦ ´ëÃ¥À̳ª °³ÀÎ¿ë º¸È£ Á¦Ç° µîÀÇ ¿¹¹æ ´ëÃ¥ÀÇ Ã¤¿ëÀ» ´õ¿í °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹é½ÅÀ̳ª Ç×¹ÙÀÌ·¯½º ¿ä¹ýÀÇ °³¹ßÀÌ ÃßÁøµÇ°í, ÀÌ °øÁßÀ§»ýÀÇ À§Çù°ú ½Î¿ì±â À§ÇØ Á¤ºÎ³ª º¸°Ç±â±¸°¡ ¿¬±¸°³¹ß¿¡ ÅõÀÚÇÔÀ¸·Î½á ½ÃÀå¿¡ »õ·Î¿î ±âȸ°¡ ź»ýÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µ°ú °ü¸® ³ë·ÂÀÇ Çʿ伺°ú ÇÔ²² °øÁߺ¸°Ç ´ç±¹°ú ¹Î°£´ÜüµéÀÌ ÀÌ ¹ÙÀÌ·¯½º°¡ ÃÊ·¡ÇÒ À§Çè Áõ°¡¸¦ ´Ù·ç·Á°í Çϱ⠶§¹®¿¡ WNV ½ÃÀåÀÇ È®´ë¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

Á¶»ç ´ë»ó ±â¾÷ ¿¹(ÁÖ¸ñÀÇ 25°³»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global West Nile Virus Market to Reach US$929.1 Million by 2030

The global market for West Nile Virus estimated at US$615.9 Million in the year 2023, is expected to reach US$929.1 Million by 2030, growing at a CAGR of 6.0% over the analysis period 2023-2030. Antivirals, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$384.8 Million by the end of the analysis period. Growth in the Antibiotics segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$167.8 Million While China is Forecast to Grow at 9.9% CAGR

The West Nile Virus market in the U.S. is estimated at US$167.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$200.7 Million by the year 2030 trailing a CAGR of 9.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global West Nile Virus Market - Key Trends and Drivers Summarized

What Is West Nile Virus and How Does It Impact Public Health?

West Nile Virus (WNV) is a mosquito-borne virus that has emerged as a significant public health concern across the globe. First identified in Uganda in 1937, the virus has since spread to various parts of the world, including North America, Europe, and parts of Asia. WNV is primarily transmitted to humans through the bite of infected mosquitoes, particularly the Culex species, which are common in many regions. While the majority of WNV infections are asymptomatic or result in mild flu-like symptoms, the virus can cause severe neurological diseases, such as encephalitis or meningitis, especially in older adults and individuals with weakened immune systems. The potential for severe outcomes, including long-term neurological damage or death, makes WNV a significant public health issue. As global travel and climate change contribute to the spread of mosquito habitats, the risk of WNV outbreaks continues to rise, necessitating increased surveillance, prevention, and treatment efforts.

Who Is Most at Risk from West Nile Virus and Why Is It So Dangerous?

West Nile Virus poses a particular threat to certain high-risk groups, including the elderly, immunocompromised individuals, and those with pre-existing health conditions such as diabetes or hypertension. These populations are more likely to develop severe symptoms if infected, including neurological complications that can lead to prolonged recovery periods or permanent disability. Additionally, residents of regions where WNV is endemic, particularly during peak mosquito season, face an increased risk of exposure. The danger of WNV lies not only in its potential to cause serious illness but also in its ability to evade early detection, as many cases are asymptomatic or present with nonspecific symptoms. This can delay diagnosis and treatment, increasing the likelihood of severe outcomes. Public health authorities emphasize the importance of preventive measures, such as mosquito control programs, public education on reducing exposure, and the development of vaccines and antiviral treatments to mitigate the impact of WNV.

What Are the Latest Trends and Innovations in Combating West Nile Virus?

The fight against West Nile Virus has seen numerous advancements in recent years, with a focus on improving detection, prevention, and treatment strategies. One of the most significant trends is the development of rapid diagnostic tests that can quickly identify WNV infections, enabling timely intervention and reducing the spread of the virus. Additionally, there is ongoing research into vaccines that could provide long-term protection against WNV, which would be a major breakthrough in controlling the virus, particularly in regions with frequent outbreaks. Advances in mosquito control technologies, such as the use of genetically modified mosquitoes and environmentally friendly insecticides, are also playing a critical role in reducing the population of WNV carriers. Furthermore, public health campaigns are increasingly leveraging digital platforms to disseminate information about WNV prevention, raising awareness about the importance of personal protective measures and community-wide mosquito control efforts. These innovations are contributing to a more comprehensive and effective response to WNV, though challenges remain in ensuring widespread access to these tools, particularly in resource-limited settings.

What Are the Key Growth Drivers for the West Nile Virus Market?

The growth in the West Nile Virus market is driven by several factors that underscore the escalating threat posed by this virus. A key driver is the increasing incidence of WNV outbreaks, fueled by global climate change, which is expanding the habitats of WNV-carrying mosquitoes into new regions. This trend is driving demand for more effective surveillance, diagnostic, and preventive measures. Technological advancements, particularly in the fields of diagnostics and mosquito control, are also propelling market growth by offering more efficient and scalable solutions for detecting and mitigating the spread of WNV. The growing awareness of WNV's potential to cause severe neurological disease is further accelerating the adoption of preventive measures, including mosquito control initiatives and personal protective products. Additionally, the push for the development of vaccines and antiviral therapies is creating new opportunities within the market, as governments and health organizations invest in research and development to combat this public health threat. These factors, coupled with the need for ongoing monitoring and control efforts, are driving the expansion of the WNV market as public health authorities and private sector entities seek to address the rising risk posed by this virus.

Select Competitors (Total 25 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â